"
Team:Arizona State/References
From 2013.igem.org
| (One intermediate revision not shown) | |||
| Line 16: | Line 16: | ||
| - | <p>William R. Heath & Francis R. Carbone (November 2001). "Cross-presentation in viral immunity and self-tolerance". Nature Reviews Immunology 1: 126–134. doi:10.1038/35100512</p> | + | <p>Arens, S. v. (2013). Predicting the efficacy of cancer vaccines by evaluating T-cell responses. OncoImmunology </p> |
| + | |||
| + | <p>Bhanuprasanth Koppolu, D. A. (2013). The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells. Biomaterials, 2359-2369.</p> | ||
| + | <p>Brenda J. Weigel, D. A. (2003). CpG Oligodeoxynucleotides Potentiate the Antitumor Effects of Chemotherapy or Tumor Resection... Clinical Cancer Research, 3105-3114.</p> | ||
| + | <p>Emmanuelle Adam, L. D.-C. (2010). Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-pathway. European Journal of Immunology, 1995-2005.</p> | ||
| + | <p>Ennis, R. (2011). Nanoparticle-Based Intracellular Delivery System of Immunomodulatory Agents for Initiation of an Anti-Tumor Immune Response. Dartmouth Undergraduate Journal of Science, 40-44.</p> | ||
| + | <p>Jong-Soo Lee, K.-S. S.-G.-J. (2000). Surface-displayed viral antigens on Salmonella carrier vaccine. Nature America, 645-648.</p> | ||
| + | <p>Laura C. Bonifaz, D. P.-I. (2004). In Vivo Targeting of Antigens to Maturing Dendritic Cellsvia the DEC-205 Receptor Improves T Cell Vaccination. Journal of Experimental Medicine, 815-824.</p> | ||
| + | <p>Li-Zhen He, A. C.-R.-T.-F. (2013). Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity. Journal of Immunology, 6259-6267.</p> | ||
| + | <p> | ||
| + | Martin A. Cheever, J. P. (2009). The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research. Clinical Cancer Research, 15, 5323-5337.</p> | ||
| + | <p>Paul Q. Hu, R. J.-W. (2004). Escherichia coli Expressing Recombinant Antigen and Listeriolysin O Stimulate Class I-Restricted CD8+ T Cells following Uptake by Human APC. Journal of Immunology, 1595-1601.</p> | ||
| + | |||
| + | |||
| + | <p>William R. Heath & Francis R. Carbone (November 2001). "Cross-presentation in viral immunity and self-tolerance". Nature Reviews Immunology 1: 126–134. doi:10.1038/35100512</p> | ||
| + | |||
<h3>Lysteriolysin O Function and Mechanism</h3> | <h3>Lysteriolysin O Function and Mechanism</h3> | ||
| + | <p>J Mengaud, M. F.-S.-D. (1988). Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infection and Immunity, 766-772. | ||
| + | Jacques Banchereau, F. B.-J. (2000). Immunology of Dendritic Cells. Annual Review of Immunology, 767-811.</p> | ||
| + | <p> | ||
| + | Reshma Singh, M. E. (2005). Fusion to Listeriolysin O and Delivery by Listeria monocytogenes Enhances the Immunogenicity of HER-2/neu and Reveals Subdominant Epitopes in the FVB/N Mouse. Journal of Immunology, 3663-3673.</p> | ||
| + | <p> | ||
| + | Vafa Shahabi, P. C. (2010). Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment. Bioengineered Bugs, 235-239.</p> | ||
| + | |||
| + | |||
<h3>GMCSF Secretion and Macrophage Recruiting</h3> | <h3>GMCSF Secretion and Macrophage Recruiting</h3> | ||
| + | <p>H. Sletta, A. T. (2007). The Presence of N-Terminal Secretion Signal Sequences Leads to Strong Stimulation of the Total Expression Levels of Three Tested Medically Important Proteins. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 906-912.</p> | ||
| + | <p>Ji Yang, D. L.-B. (2007). Transcriptional Regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM Cluster, Encoding the Type II Secretion Pathway in Enterotoxigenic Escherichia coli. Journal of Bacteriology, 142-150.</p> | ||
| + | <p>Jonathan B. Mitchem, D. J. (2013). Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses. Cancer Research , 1128-1141.</p> | ||
| + | <p>Katharina A. Remer, M. B. (2009). Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88. International Journal of Medical Microbiology , 467-478.</p> | ||
| + | <p>Kheng Oon Low, N. M. (2011). An effective extracellular protein secretion by an ABC transporter system inEscherichia coli:. J Ind Microbiol Biotechnology, 1587-1597.</p> | ||
| + | <p>Kheng Oon Low, N. M. (2013). Optimisation of signal peptide for recombinant protein secretion in bacterial hosts. Applied Microbial Biotechnology, 3811-3826.</p> | ||
| + | <p>Smyth, M. H. (2013). Making Macrophages Eat Cancer. Science, 341-343. | ||
| + | Suzanne A. Miles, A. D. (2009). CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Advanced Drug Delivery Review, 275-282.</p> | ||
| + | <p>Whiteside, T. L. (2005). Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention. Seminars in Cancer Biology, 633-646.</p> | ||
| + | <p> | ||
| + | Yu Feng, e. a. (2006). Prification of a non-tagged recombinant BCG heat shock protein 65-Her2 peptide fusion protein from Escherichia coli. Proteint Expression and Purification, 390-395.</p> | ||
| + | |||
| + | |||
| + | |||
</body> | </body> | ||
</html> | </html> | ||
Latest revision as of 03:47, 28 September 2013
MHC Antigen Presentation
Arens, S. v. (2013). Predicting the efficacy of cancer vaccines by evaluating T-cell responses. OncoImmunology
Bhanuprasanth Koppolu, D. A. (2013). The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells. Biomaterials, 2359-2369.
Brenda J. Weigel, D. A. (2003). CpG Oligodeoxynucleotides Potentiate the Antitumor Effects of Chemotherapy or Tumor Resection... Clinical Cancer Research, 3105-3114.
Emmanuelle Adam, L. D.-C. (2010). Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-pathway. European Journal of Immunology, 1995-2005.
Ennis, R. (2011). Nanoparticle-Based Intracellular Delivery System of Immunomodulatory Agents for Initiation of an Anti-Tumor Immune Response. Dartmouth Undergraduate Journal of Science, 40-44.
Jong-Soo Lee, K.-S. S.-G.-J. (2000). Surface-displayed viral antigens on Salmonella carrier vaccine. Nature America, 645-648.
Laura C. Bonifaz, D. P.-I. (2004). In Vivo Targeting of Antigens to Maturing Dendritic Cellsvia the DEC-205 Receptor Improves T Cell Vaccination. Journal of Experimental Medicine, 815-824.
Li-Zhen He, A. C.-R.-T.-F. (2013). Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity. Journal of Immunology, 6259-6267.
Martin A. Cheever, J. P. (2009). The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research. Clinical Cancer Research, 15, 5323-5337.
Paul Q. Hu, R. J.-W. (2004). Escherichia coli Expressing Recombinant Antigen and Listeriolysin O Stimulate Class I-Restricted CD8+ T Cells following Uptake by Human APC. Journal of Immunology, 1595-1601.
William R. Heath & Francis R. Carbone (November 2001). "Cross-presentation in viral immunity and self-tolerance". Nature Reviews Immunology 1: 126–134. doi:10.1038/35100512
Lysteriolysin O Function and Mechanism
J Mengaud, M. F.-S.-D. (1988). Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infection and Immunity, 766-772. Jacques Banchereau, F. B.-J. (2000). Immunology of Dendritic Cells. Annual Review of Immunology, 767-811.
Reshma Singh, M. E. (2005). Fusion to Listeriolysin O and Delivery by Listeria monocytogenes Enhances the Immunogenicity of HER-2/neu and Reveals Subdominant Epitopes in the FVB/N Mouse. Journal of Immunology, 3663-3673.
Vafa Shahabi, P. C. (2010). Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment. Bioengineered Bugs, 235-239.
GMCSF Secretion and Macrophage Recruiting
H. Sletta, A. T. (2007). The Presence of N-Terminal Secretion Signal Sequences Leads to Strong Stimulation of the Total Expression Levels of Three Tested Medically Important Proteins. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 906-912.
Ji Yang, D. L.-B. (2007). Transcriptional Regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM Cluster, Encoding the Type II Secretion Pathway in Enterotoxigenic Escherichia coli. Journal of Bacteriology, 142-150.
Jonathan B. Mitchem, D. J. (2013). Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses. Cancer Research , 1128-1141.
Katharina A. Remer, M. B. (2009). Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88. International Journal of Medical Microbiology , 467-478.
Kheng Oon Low, N. M. (2011). An effective extracellular protein secretion by an ABC transporter system inEscherichia coli:. J Ind Microbiol Biotechnology, 1587-1597.
Kheng Oon Low, N. M. (2013). Optimisation of signal peptide for recombinant protein secretion in bacterial hosts. Applied Microbial Biotechnology, 3811-3826.
Smyth, M. H. (2013). Making Macrophages Eat Cancer. Science, 341-343. Suzanne A. Miles, A. D. (2009). CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Advanced Drug Delivery Review, 275-282.
Whiteside, T. L. (2005). Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention. Seminars in Cancer Biology, 633-646.
Yu Feng, e. a. (2006). Prification of a non-tagged recombinant BCG heat shock protein 65-Her2 peptide fusion protein from Escherichia coli. Proteint Expression and Purification, 390-395.
